134 related articles for article (PubMed ID: 8834646)
1. [Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf)].
Stachowski J; Runowski D; Kramer J; Madaliński K; Maciejewski J; Baldamus CA
Przegl Lek; 1995; 52(9):445-54. PubMed ID: 8834646
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients.
Stachowski J; Kramer J; Füst G; Maciejewski J; Baldamus CA; Petrányi GG
Scand J Immunol; 1995 Jul; 42(1):60-5. PubMed ID: 7631146
[TBL] [Abstract][Full Text] [Related]
3. Genetic regulation of the impaired immune response to hepatitis-B vaccine associated with low TCR density in end stage renal disease patients: contribution of complement C4 and factor B alleles.
Kramer J; Stachowski J; Barth C; Ujhelyi E; Tarján V; Sulowicz W; Füst G; Baldamus CA
Immunol Lett; 1997 Oct; 59(1):13-9. PubMed ID: 9334852
[TBL] [Abstract][Full Text] [Related]
4. Investigation of allotypes of HLA class III (C2, BF and C4) in patients with schizophrenia.
Wang C; Jian BX; Jiang XD; Zhao XZ
Chin Med J (Engl); 1992 Apr; 105(4):316-8. PubMed ID: 1618015
[TBL] [Abstract][Full Text] [Related]
5. [Changes in the polymorphism and concentrations of components of the class II complement after orthotopic transplantation of the liver].
Uring-Lambert B; Valette C; Hartmann D; Wolf P; Hauptmann G
Gastroenterol Clin Biol; 1995 Dec; 19(12):976-9. PubMed ID: 8729408
[TBL] [Abstract][Full Text] [Related]
6. Allotyping human complement factor B in Asian Indian type 1 diabetic patients.
Kumar N; Kaur G; Tandon N; Mehra NK
Tissue Antigens; 2008 Dec; 72(6):517-24. PubMed ID: 19000152
[TBL] [Abstract][Full Text] [Related]
7. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
[TBL] [Abstract][Full Text] [Related]
8. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G.
Kaur G; Kumar N; Szilagyi A; Blasko B; Fust G; Rajczy K; Pozsonyi E; Hosso A; Petranyi G; Tandon N; Mehra N
Hum Immunol; 2008 Sep; 69(9):580-7. PubMed ID: 18657583
[TBL] [Abstract][Full Text] [Related]
10. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination.
Kacprzak-Bergman I; Nowakowska B
Arch Immunol Ther Exp (Warsz); 2005; 53(2):139-42. PubMed ID: 15928582
[TBL] [Abstract][Full Text] [Related]
11. Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen.
Whittingham S; Mathews JD; Schanfield MS; Matthews JV; Tait BD; Morris PJ; Mackay IR
Clin Exp Immunol; 1980 Apr; 40(1):8-15. PubMed ID: 6930337
[TBL] [Abstract][Full Text] [Related]
12. The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients.
Ozdemir FN; Micozkadioglu H; Arat Z; Turan M; Gulmus S; Haberal M
Transplant Proc; 2004 Nov; 36(9):2615-7. PubMed ID: 15621103
[TBL] [Abstract][Full Text] [Related]
13. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
[TBL] [Abstract][Full Text] [Related]
14. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
15. Bf and C4 phenotypes in patients with psoriasis.
Wyatt RJ; Wang C; Hudson EC; Jones RM; Noah PW; Rosenberg EW
Acta Derm Venereol Suppl (Stockh); 1989; 146():211-3. PubMed ID: 2609873
[TBL] [Abstract][Full Text] [Related]
16. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India.
Das K; Gupta RK; Kumar V; Singh S; Kar P
Trop Gastroenterol; 2004; 25(3):113-5. PubMed ID: 15682656
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G
Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573
[TBL] [Abstract][Full Text] [Related]
18. HLA-B27 and allotypes of complement components in ankylosing spondylitis.
Gran JT; Teisberg P; Olaissen B; Thorsby E; Husby G
J Rheumatol; 1984 Jun; 11(3):324-6. PubMed ID: 6610755
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
[TBL] [Abstract][Full Text] [Related]
20. Complement factor B allotypes in the susceptibility and severity of coeliac disease in patients and relatives.
da Rosa Utiyama SR; da Silva Kotze LM; de Messias Reason IT
Int J Immunogenet; 2005 Oct; 32(5):307-14. PubMed ID: 16164698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
